Departamento de Farmacobiología, Cinvestav, Sede sur, Mexico City, Mexico.
Departamento de Farmacobiología, Cinvestav, Sede sur, Mexico City, Mexico.
Brain Res. 2024 Jul 1;1834:148915. doi: 10.1016/j.brainres.2024.148915. Epub 2024 Apr 4.
Bestrophin-1 and anoctamin-1 are members of the calcium-activated chloride channels (CaCCs) family and are involved in inflammatory and neuropathic pain. However, their role in pain hypersensitivity induced by REM sleep deprivation (REMSD) has not been studied. This study aimed to determine if anoctamin-1 and bestrophin-1 are involved in the pain hypersensitivity induced by REMSD. We used the multiple-platform method to induce REMSD. REM sleep deprivation for 48 h induced tactile allodynia and a transient increase in corticosterone concentration at the beginning of the protocol (12 h) in female and male rats. REMSD enhanced c-Fos and α2δ-1 protein expression but did not change activating transcription factor 3 (ATF3) and KCC2 expression in dorsal root ganglia and dorsal spinal cord. Intrathecal injection of CaCC, a non-selective bestrophin-1 blocker, and T16A, a specific anoctamin-1 blocker, reverted REMSD-induced tactile allodynia. However, T16A had a higher antiallodynic effect in male than female rats. In addition, REMSD increased bestrophin-1 protein expression in DRG but not in DSC in male and female rats. In marked contrast, REMSD decreased anoctamin-1 protein expression in DSC but not in DRG, only in female rats. Bestrophin-1 and anoctamin-1 promote pain and maintain tactile allodynia induced by REM sleep deprivation in both male and female rats, but their expression patterns differ between the sexes.
Bestrophin-1 和 anoctamin-1 是钙激活氯离子通道 (CaCCs) 家族的成员,参与炎症和神经病理性疼痛。然而,它们在快速眼动睡眠剥夺 (REMSD) 引起的疼痛敏化中的作用尚未研究。本研究旨在确定 anoctamin-1 和 bestrophin-1 是否参与 REMSD 诱导的疼痛敏化。我们使用多平台方法诱导 REMSD。REMS 剥夺 48 小时会在协议开始时(12 小时)引起雌性和雄性大鼠的触觉过敏和皮质酮浓度的短暂增加。REMSD 增强了背根神经节和背柱中的 c-Fos 和 α2δ-1 蛋白表达,但未改变激活转录因子 3 (ATF3) 和 KCC2 表达。鞘内注射 CaCC(非选择性 bestrophin-1 阻断剂)和 T16A(特异性 anoctamin-1 阻断剂)可逆转 REMSD 诱导的触觉过敏。然而,T16A 在雄性大鼠中的抗痛觉过敏作用高于雌性大鼠。此外,REMSD 增加了雄性和雌性大鼠 DRG 中的 bestrophin-1 蛋白表达,但不增加 DSC 中的表达。相比之下,REMSD 降低了雌性大鼠 DSC 中的 anoctamin-1 蛋白表达,但不降低 DRG 中的表达。Bestrophin-1 和 anoctamin-1 促进了雄性和雌性大鼠 REM 睡眠剥夺引起的疼痛,并维持了触觉过敏,但它们在性别之间的表达模式不同。